China Animal

China Animal: CIMB maintains Buy with $0.52 TP. Highlight that Fidelity was recently seen upping stakes in Co. to 8% ahead of grp’s HK dual listing, while grp has recently obtained the regulatory approvals to commence commercial production and sales of its FMD vaccines….

Expects a solid 2H results from grp next week, while potential catalyst would include fast tract expansion through M&A of key Vaccines producers and higher multiples from dual-listing in HK.